Management & Regulatory

Reporting Patient Safety Incidents to the LFPSE System
Management & Regulatory Reporting Patient Safety Incidents to the LFPSE System

The landscape of clinical governance within community pharmacies has undergone a significant transformation with the full implementation of the Learn from Patient Safety Events service. Since the transition from the older National Reporting and Learning Service was finalized, the expectation for

POSTECH Launches K-BIGHEART to Revolutionize Bioengineering
Management & Regulatory POSTECH Launches K-BIGHEART to Revolutionize Bioengineering

The global landscape of biotechnology is undergoing a fundamental shift as the Pohang University of Science and Technology establishes a pioneering research hub designed to bridge the gap between laboratory discovery and commercial viability. This new entity, known as the Global Healthcare &

Next-Generation IBD Therapeutics – Review
Management & Regulatory Next-Generation IBD Therapeutics – Review

The persistent struggle to manage chronic inflammatory conditions has historically forced patients to choose between systemic immunosuppression and the logistical burden of frequent clinical infusions. While the introduction of biologics revolutionized the treatment of ulcerative colitis and

B Capital Joins Japan’s AMED to Scale Biotech Startups
Management & Regulatory B Capital Joins Japan’s AMED to Scale Biotech Startups

Japan’s life sciences landscape is undergoing a massive transformation as the nation leverages its deep scientific heritage to address the complexities of modern drug discovery and healthcare technology. This evolution is being catalyzed by the Japan Agency for Medical Research and Development,

Review of Foundayo Weight Loss Pill
Management & Regulatory Review of Foundayo Weight Loss Pill

Achieving substantial weight reduction has historically required a combination of rigorous discipline and, more recently, the daunting prospect of weekly self-administered injections. This shift toward pharmacological intervention has been revolutionary, yet many individuals remain hesitant to

EU Approves Imfinzi for Early Gastric and GEJ Cancers
Management & Regulatory EU Approves Imfinzi for Early Gastric and GEJ Cancers

The European Commission’s recent authorization of AstraZeneca’s Imfinzi marks a significant shift in the therapeutic landscape for patients battling resectable gastric and gastro-esophageal junction cancers across the continent. This decision formalized the use of durvalumab as a perioperative

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later